In addition, the HBV patients with HCC and the other two groups without HCC (healthy controls and HBV patients without HCC) had statistical significant different laboratory results for T-Bil, D-Bil, AST, ALT, ALB, GGT, AFP (P<0.001), and HBV-DNA (P<0.05). This evidence concerns the gene GPT and hepatocellular carcinoma.